Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Evaluating the value of travel points against cash back can impact your rewards strategy. Discover which option offers the greatest benefits for your needs.
26,201 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
When a luxury carmaker unveils something truly polarizing, investors sit up. This piece breaks down what ferrari laun...
Meta Platforms looks cheaper than it has in years, with growth signals that could power a turnaround by 2027. This gu...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
A single headline can move stock in moments, but the real story is rarely a simple one. This article dives into why a...
Hycroft Mining stock dropped 18% this week as gold and silver prices slid and investors weighed development risk. Thi...
Nextpower (NXT) 2026 earnings provide a window into the company’s growth engine and future trajectory. This piece bre...
Two AI giants, Microsoft and Nvidia, offer very different routes to growth. This guide breaks down why one might fit ...